MORGAN, M. R. Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism. Science and Technology Law Review, [S. l.], v. 11, 2009. DOI: 10.7916/stlr.v11i0.3846. Disponível em: https://journals.library.columbia.edu/index.php/stlr/article/view/3846. Acesso em: 12 apr. 2024.